Cassady Schiller Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$354K Buy
458
+42
+10% +$34.8K 0.13% 80
2024
Q3
$369K Hold
416
0.13% 79
2024
Q2
$377K Hold
416
0.15% 73
2024
Q1
$324K Sell
416
-18
-4% -$12.8K 0.14% 83
2023
Q4
$253K Buy
434
+83
+24% +$48.4K 0.13% 90
2023
Q3
$189K Buy
351
+47
+15% +$24.2K 0.1% 105
2023
Q2
$143K Hold
304
0.08% 126
2023
Q1
$104K Hold
304
0.05% 143
2022
Q4
$111K Buy
+304
New +$108K 0.07% 126
2022
Q1
Sell
-320
Closed -$88K 377
2021
Q4
$88K Buy
+320
New +$81.1K 0.05% 148

Other funds holding LLY

Cassady Schiller Wealth Management's LLY Position: Q4 2024 in Review

Cassady Schiller Wealth Management increased its Eli Lilly (LLY) stake by 10% in Q4 2024, buying an estimated $34.8K and bringing the position to 458 shares worth $354K. The position accounts for 0.13% of the portfolio, ranked #80.

Cassady Schiller Wealth Management first reported a position in LLY in Q4 2021 and has held it in 10 quarters since. The position peaked at $377K in Q2 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Cassady Schiller Wealth Management held 458 shares of Eli Lilly worth $354K as of Q4 2024.
  • Cassady Schiller Wealth Management bought 42 Eli Lilly shares in Q4 2024, an estimated $34.8K.
  • Eli Lilly made up 0.13% of Cassady Schiller Wealth Management's portfolio in Q4 2024, its #80 holding.
  • Cassady Schiller Wealth Management first reported a position in Eli Lilly in Q4 2021 and has held it in 10 quarters since.
  • Cassady Schiller Wealth Management's Eli Lilly position peaked at $377K in Q2 2024.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Cassady Schiller Wealth Management's 13F filing for Q4 2024, filed 10 Feb 2025.